Pharmacognosy has developed rapidly in recent years and now represents a highly interdisciplinary science. At the boundary between pharmacognosy and molecular biology, molecular pharmacognosy has developed as a new borderline discipline. Using the method and technology of molecular biology, molecular pharmacognosy focuses on resolving a wide range of challenging problems, such as distinguishing herbal and animal drug populations by molecular marker assay, conserving and utilizing wild resources on the basis of knowledge of genetic diversity, investigating the mechanism of active compound accumulation and obtaining new resources with higher quality through genetic engineering. Recent research results show that molecular pharmacognosy has extended the scope of pharmacognostical science and plays an important role in the safe and efficient usage of crude drugs.
Crude drugs are natural, unrefined substances derived from plant, animal and mineral sources that are widely used in the prevention of disease and as dietary supplements [1] . Pharmacognosy focuses on the study of the origin, production, identification, quality evaluation and preservation of crude drugs. In the past 200 years, pharmacognosy has developed from traditional herbalism to the investigation of the "natural" character of crude drugs by the combination of phamacognosy with the theory and methods of modern science. Like many contemporary fields, pharmacognosy now represents a highly interdisciplinary science. Theory and methodology in phytochemistry, biochemistry, cell biology, molecular biology and genetics are all used in pharmacognostical studies. Between pharmacognosy and molecular biology, molecular pharmacognosy has developed as a new borderline discipline and plays an important role in the identification, biosynthesis, and evaluation of crude drugs at the genetic level.
The development of pharmacognosy
Pharmacognosy is the oldest branch of the profession of pharmacy and its development is highly connected with society and science development. Though pharmacognosy has undergone significant changes in recent years, there are still some problems needed to be resolved. 1) The quick, over-exploitation that has caused the progressive reduction of natural resources. In China, there are 102 medicinal plant species listed as rare and endangered plants. New theories and methods need to be developed to help the preservation of natural resources [2] . 2) There are many multi-origin drugs in the Chinese Pharmacopoeia; adulteration of precious and famous drugs is still common in the market and animal drugs can only be identified by morphological characterization [3] . Effective methods are needed to identify the species and their authenticity. 3) Little is known about the inner factors that affect the quality of crude drugs and cultivation technology is still limited. To resolve the above problems, the development of new ideas and technology is urgent.
Pharmacognosy and molecular biology
The discovery of the structure of DNA in 1953 marked a milestone in the history of life science and gave rise to modern molecular biology, which is largely concerned with understanding how genes control the chemical processes within cells. DNA, which contains the genetic instructions, connects molecular biology and pharmacognosy together. A new borderline discipline -molecular pharmacognosy, a term that came into use in 1995-is forming at the boundary between pharmacognosy and molecular biology. Using the methods and technology of molecular biology, molecular pharmacognosy is focused on resolving a wide range of challenging problems. Molecular markers were used for the identification of species, cultivars and production area, and became a powerful weapon to identify adulteration and substitution. The candidate genes for active compound accumulation can be cloned to elucidate the formation mechanism. Cultivar improvements and new crude drugs could be achieved through genetic engineering. Conservation and utilization of wild resources could be based on knowledge of genetic diversity. Recent research has shown that molecular pharmacognosy has extended the scope of pharmacognostical science and plays an important role in the safety and efficient usage of crude drugs.
Application of molecular pharmacognosy
Cultivar identification: Identification of crude drug cultivars is very important because they show different medical qualities and differ in price. Molecular marker identification has the advantage of high accuracy and good reproducibility, compared with the morphological, microscopic and chemical marker assay. Some molecular identification methods have been successfully used for cultivar identification, including RAPD, SSR, AR-PCR, MARMS, APAPD and PCR-RFLP, which are based on the technology of PCR and electrophoresis, and SNP and DNA barcoding, which are based on sequencing procedures. RAPD technology had been successfully used to distinguish 26 samples of trichosanthin and analogues from 13 species and 3 varieties [4] . It was reported that APAPD and MARMS methods identified five kinds of Panax Ginseng related species [5, 6] . DNA barcoding technology has enormous potential for cultivar identification, and mitochondrial COI (cytochrome c oxidase I) gene, nuclear ITS fragments and chloroplast trnH-psbA sequence are good candidates for this development [7, 8] .
Resource protection: The information on genetic diversity could guide the protection and development of medicinal resources, especially of the rare and endangered ones. Molecular marker technology has an obvious advantage in evaluating the genetic diversity of species by dividing the evolutionary significant units, analyzing the species relationship, selecting the marker of fine germplasm resources and applying molecular marker-assisted breeding. Evaluation of the genetic diversity and genetic structure of Cistanche deserticola and C. tubulosa, two endangered medical plants, provided evidence for the protection of wild resources [9] . Molecular phy1ogeography, being used to analyze genetic variation of population, provided a new theory and method for the genetic diversity study [10, 11] .
Formation mechanism of medicinal materials with good quality:
The quality of medicinal materials is highly affected by their genetic basis and ecological environment. Genetic material is the foundation, and ecological factors affect the absorption and distribution of inorganic elements and accumulation of secondary metabolites. Investigating the formation mechanism of medicinal materials of good quality will be helpful for molecular breeding and cultivation of medicinal materials. At present, some medicinal plant genes have been cloned and shown to play important roles in the biosynthesis of secondary metabolites [12, 13] , control of gene expression [14] and signal transduction [15] . These will improve the study of formation mechanisms of medicinal materials with good quality [16] .
Production of active compounds:
Transgenic technology has been successfully used to obtain transgenic medicinal plants which have either disease, insect, drought and salinity resistance, or have higher production of active compounds. Recently, Bt and TMV coat protein gene has been introduced into medical plants and provided resistance to insect attack and disease [17] . The production of tanshinone was obtained from hairy roots and suspension cells of Salvia miltiorrhiza [18, 19] . The content of scopolamine in transgenic Hyoscyamus niger was increased 9.6-fold compared with the wild-type [20] . Artemisinic acid, the intermediate of artemisinin, can be directly produced by an engineered yeast strain with a production rate of 100 mg/L [21] . The content of artemisinic acid can also been enhanced by change to the subcellular distribution of terpene biosynthase through genetic engineering in tobacco [22] .
Conclusions and perspective
Molecular pharmacognosy has developed rapidly with in recent years, and there has been much Molecular pharmacognosy Natural Product Communications Vol. 4 (11) 2009 1613 progress on cultivar identification, resource protection, quality formation mechanisms, and active compound production. The great breakthrough of molecular pharmacognosy could be anticipated on quality formation mechanisms, cultivar improvement, and a DNA barcoding database in the near future.
